Next Article in Journal / Special Issue
The Outcomes of Patients with Haemoglobin Disorders in Cyprus: A Joined Report of the Thalassaemia International Federation and the Nicosia and Paphos Thalassaemia Centres (State Health Services Organisation)
Previous Article in Journal
Is the Role of Hepcidin and Erythroferrone in the Pathogenesis of Beta Thalassemia the Key to Developing Novel Treatment Strategies?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Thalassemia Reports
Volume 12
Issue 4
10.3390/thalassrep12040018
Review Report
thalassrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

Redesigning New Policy Options for Thalassemia Prevention in Sri Lanka

Thalass. Rep. 2022, 12(4), 135-142; https://doi.org/10.3390/thalassrep12040018
by Nadeeja Amarasinghe 1, Amila Amarasena 2, Anoj Thabrew 3, Prabhath Werawatte 4, Anuja Premawardhena 5,*, Farnaz Malik 6, Mohamed Abusayeed 7 and Champika Wickramasinghe 7
Reviewer 1:
Suthat Fucharoen
Reviewer 2: Anonymous
Thalass. Rep. 2022, 12(4), 135-142; https://doi.org/10.3390/thalassrep12040018
Submission received: 8 September 2022 / Revised: 8 October 2022 / Accepted: 12 October 2022 / Published: 19 October 2022
(This article belongs to the Special Issue Thalassaemia: A Complex Mix of Genetic Entities Challenging Healthcare Providers Globally)

Round 1

Reviewer 1 Report

This is a well designed study before the implementation of thalassemia control.  As we know there are a number of factors that may affect the program of prevention depends on the location, religious, social engagement and legal issue in each country. It is wisely to study different approaches in the control program to identify the best strategy before implementation the program nationwide.

Author Response

We thank the reviewer for the valuable comments. The cultural, social implications will be well studied before the new policies will be implemented. This is specially relevant to TOP followed by PND in Sri Lanka, where though the technology is available, the legal system is still rigid. Wider social discussions about the topic has still not happened for the procedure to be widely accepted.

Reviewer 2 Report

This is a well written paper where 3 new Policy Options for preventing thalassemia in Sri Lanka have been presented and the most beneficial and cost effective one suggested for implementation. As data from other regional prevention programmes from Iran and UK have been used for some of the cost calculations, this may be mentioned as one of the limitations. Also, in Policy Option 3 why was cost of fetal sampling by amniocentesis taken rather than a first trimester approach like CVS? This may be clarified.

Author Response

Thank you for your valuable comments. The reason for not using CV sampling for PND, is that the foetal medicine specialists in Sri Lanka are at present more comfortable in doing the procedure of amniocentesis at 16 weeks, rather than doing the former. 

Back to TopTop